Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY: VXF )

169.32 +3.88 (+2.35%)
Streaming Delayed Price Updated: 1:59 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9 Next >
American Airlines Withdraws Full-Year Guidance Amid Economic Uncertainty, Reports Narrower Q1 Losses
CEO Robert Isom highlighted that the airline’s actions over the past several years to refresh its fleet, manage costs, and strengthen its balance sheet position it well for the uncertainty the industry... 
Via Stocktwits
Topics Earnings
Exposures Financial
TNF Pharmaceuticals To Use AI To Recruit Patients For Drug Development: Retail Stays Bearish
The company stated that the TNF-Renova partnership is analyzing data from 30,000 patients to identify high-risk patients. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays Bearish
During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries. 
Via Stocktwits
Exposures Product Safety
Faraday Future Expects Short Term Impact From Trump Tariffs But Retail Is Positive
The company said that its second brand, Faraday X, plans to source components internationally in the early phase of production. 
Via Stocktwits
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
Comerica Q1 2025 Earnings Top Wall Street Estimates, Revenue Fails To Meet Expectations As Loan Demand Remains Muted
CEO Curtis C. Farmer said that stronger-than-expected non-interest-bearing balances and proactive deposit pricing strategies offset the impact of muted loan demand. 
Via Stocktwits
Topics Government Stocks
Exposures Political US Equities
uniQure Stock Jumps On FDA’s Breakthrough Therapy Designation For Investigational Gene Therapy: Retail’s Optimistic
The new designation is in addition to the existing Regenerative Medicine Advanced Therapy, Orphan Drug, and Fast Track designations granted to AMT-130. 
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal Product Safety
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed
Every eight shares of Biomerica’s pre-split common stock issued and outstanding will be automatically reclassified as and converted into one new share of Biomerica’s common stock on Monday. 
Via Stocktwits
Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled
The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed. 
Via Stocktwits
Topics Government
Exposures Political
Cara Therapeutics Stock Jumps 10% After Announcing 1-for-3 Reverse Stock Split: Retail Sentiment Soars
On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the... 
Via Stocktwits
Topics Economy
Exposures COVID-19 Interest Rates
Bath & Body Works Stock Upgraded By Piper Sandler On Strong Brand Interest, Attractive Share Price: Retail Investors Very Interested
The brand was a popular choice for fragrances among teenagers in the U.S., according to a Piper Sandler survey. 
Via Stocktwits
WeightWatchers Reportedly Considers Bankruptcy Amid Business Struggles, Debt Woes: Retail Traders On Edge
hares of the company, which is struggling with a declining business and high debt levels, fell over 60% after the report. 
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal
Phio Pharmaceuticals Stock Soars On Clearance To Escalate Dose In Skin Cancer Treatment Trial: Retail’s Thrilled
CEO Robert Bitterman said the company is optimistic that the clinical trial will continue to demonstrate that PH-762 may present a viable non-surgical alternative to existing modes of therapy for skin... 
Via Stocktwits
Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode
Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes. 
Via Stocktwits
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves
The company said that the launch is in partnership with Tirana-based pharmaceutical company Pharma Cell, which will serve as the distributor in the country. 
Via Stocktwits
Topics Economy Government
Exposures Interest Rates Political
iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish
However, the company said that the study does not prove statistical significance and only involves a single administration of the antibody. 
Via Stocktwits
Topics Economy
Exposures Interest Rates
Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High
The company said that net proceeds from the offering will be used for the continued clinical development of product candidates, as working capital, and for other general corporate purposes. 
Via Stocktwits
Topics Government
Exposures Political
Rivian Reports 36% Drop in Q1 Deliveries, But Retail Continues To Be Positive
Truist Securities noted that the numbers aligned with the company’s prior commentary and street estimates, although the shares could see headwinds today from Tesla reporting Q1 deliveries below... 
Via Stocktwits
Interactive Brokers Stock Rallies On Strong March Metrics — Retail Stays Optimistic
IBKR announced a 44% year-over-year jump in its daily average revenue trades to 3.471 million. Client accounts rose 32% YoY to 3.62 million during the month. 
Via Stocktwits
Topics Bonds
Exposures Debt Markets
Polar Power Stock In Spotlight After Q4 Revenue Declines But Losses Narrow — Retail’s Not Convinced
Revenue fell 27% year over year to $2.62 million during the quarter, while the company’s net loss narrowed to $3 million or $1.22 per share compared to a loss of $3.16 million or $1.66 per share in the... 
Via Stocktwits
Topics Electric Vehicles
Exposures Electric Vehicles
Forge Global Stock Tumbles 12% After Board Approves 1-For-15 Reverse Split — Retail’s Still Hopeful
Forge Global said the reverse stock split is intended to bring the company into compliance with the minimum bid price requirement for continued listing on the New York Stock Exchange. 
Via Stocktwits
LPL Financial Holdings To Acquire Commonwealth Financial Network For $2.7B In Cash — Retail Turns Neutral
LPL Financial also announced that it has commenced an underwritten public offering of $1.5 billion of its common stock. 
Via Stocktwits
Topics Government World Trade
Exposures Political Tariff
FTC Solar Q4 Revenue Tops Estimates But Losses Exceed Wall Street Projections — Retail Stays Bullish
The company also announced a 5-GW supply arrangement with Recurrent Energy, a utility-scale solar developer. 
Via Stocktwits
Topics Energy
Exposures Electricity Generation
Hyperscale Data Stock Drops Despite Completing First Nvidia GPU Installation – But Retail Turns Bullish
According to the company, the initial deployment of Nvidia GPUs is part of a broader effort to expand infrastructure that supports the increasing computational demands of enterprise and cloud-native... 
Via Stocktwits
Topics Artificial Intelligence Bankruptcy Energy
Exposures Artificial Intelligence Financial Fossil Fuels
Femasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be Optimistic
The company said that as of the end of 2024, it had an accumulated deficit of $127.2 million and cash and cash equivalents of only $3.5 million. 
Via Stocktwits
PDS Biotechnology Stock In Spotlight On Better-Than-Feared 2024 Loss – Retail Stays Bearish
The company said the reduced losses were primarily due to decreased operating expenses. 
Via Stocktwits
Better Choice Stock Surges Ahead of Q4 Earnings: Retail Sentiment Turns Upbeat
Sentiment on Stocktwits turned ‘bullish’ on Wednesday compared to ‘bearish’ a week ago. 
Via Stocktwits
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars
The company said on Wednesday that a single administration of the implant in healthy rats resulted in 20% lower body weight through a 91-day treatment period as compared to a control group that... 
Via Stocktwits
Vertiv Stock Slides After TD Cowen Flags Slower Data Center Equipment Purchasing As Negative For Company — But Retail’s Optimistic
TD Cowen reportedly added that hyperscale redesigns for higher densities are slowing down DC equipment purchasing, which the firm views negatively for orders in the first half of 2025 for Vertiv. 
Via Stocktwits
Allurion Stock Tumbles Over Disappointing Quarterly Earnings, Revenue Guidance – But Retail’s Not Concerned
Allurion attributed the fall in Q4 revenue to a temporary suspension of sales in France, coupled with macroeconomic headwinds in certain markets, which caused lower reorder rates. 
Via Stocktwits
REX Stock Draws Investor Attention After Q4 Earnings, Revenue Top Wall Street Estimates: Retail’s On Wait-And-Watch Mode
CEO Zafar Rizvi acknowledged the weaker crush spread environment, similar to what was seen during the fourth quarter, continuing into the first quarter of 2025. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.